While women prioritize the well-being of their loved ones, their own health often takes a back seat, leaving them vulnerable to several silent killer diseases. These illnesses, often asymptomatic in their early stages, can significantly impact women’s health and overall quality of life. Continue Reading
AstraZeneca India, a pharmaceutical company, announced on Friday that the Drugs Controller General of India had given the go-ahead to commercialise its medication for the treatment of breast cancer. In adults with early breast cancer who have previously received neoadjuvant or adjuvant chemotherapy, the Drugs Controller General of India (DCGI) has approved Lynparza Continue Reading